Healthcare -
Biotechnology - NYSE - US
$ 7.61
-9.17 %
$ 806 M
Market Cap
-2.59
P/E
CASH FLOW STATEMENT
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Arcus Biosciences, Inc.
| Net Income | -283 M |
| Depreciation & Amortization | 10 M |
| Capital Expenditures | -6 M |
| Stock-Based Compensation | 76 M |
| Change in Working Capital | 22 M |
| Others | -4 M |
| Free Cash Flow | -176 M |
Cash Flow
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | |
|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||||||
| Net Income | (283.0) | (307.0) | (267.0) | 52.8 | (122.9) | (84.7) | (49.6) | (53.1) | (18.0) |
| Depreciation & Amortization | 10.0 | 8.0 | 6.0 | 3.8 | 4.2 | 3.6 | 3.7 | 2.6 | 1.3 |
| Deferred Income Tax | 0 | 0 | 0 | 4.8 | 0 | 0 | (2.1) | 0.4 | 90 K |
| Stock Based Compensation | 76.0 | 73.0 | 65.0 | 55.0 | 22.0 | 9.0 | 3.9 | 0.5 | 90 K |
| Other Operating Activities | 5.0 | (9.0) | 11.0 | 3.5 | 46 K | (1.4) | (0.2) | 98 K | 90 K |
| Change in Working Capital | 22.0 | (71.0) | 623.0 | (375.6) | 208.1 | 0.1 | 1.3 | 24.6 | 3.6 |
| Cash From Operations | (170.0) | (306.0) | 438.0 | (256.2) | 111.2 | (73.5) | (43.0) | (25.1) | (12.9) |
| INVESTING CASH FLOW | |||||||||
| Capital Expenditures | (6.0) | (24.0) | (12.0) | (26.1) | (3.1) | (1.9) | (3.7) | (5.5) | (4.1) |
| Other Items | (78.0) | 218.0 | (401.0) | 22.2 | (431.3) | 61.1 | (109.7) | (43.6) | (34.8) |
| Cash From Investing Activities | (84.0) | 194.0 | (413.0) | (3.9) | (434.4) | 59.2 | (113.4) | (49.1) | (38.9) |
| FINANCING CASH FLOW | |||||||||
| Common Stock Repurchased | 0 | 0 | 0 | 6 K | 54 K | 94 K | 0 | 0 | 0 |
| Total Debt Repaid | 47.0 | 0 | 0 | 5.0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 2.0 | 8.0 | 33.0 | 12.3 | 4.7 | 1.2 | 4.0 | 107.4 | 70.1 |
| Cash From Financing Activities | 277.0 | 33.0 | 33.0 | 237.3 | 438.7 | 1.1 | 129.1 | 107.4 | 70.1 |
| CHANGE IN CASH | |||||||||
| Net Change In Cash | 23.0 | (79.0) | 58.0 | (22.7) | 115.5 | (13.1) | (27.4) | 33.3 | 18.3 |
| FREE CASH FLOW | |||||||||
| Free Cash Flow | (176.0) | (330.0) | 426.0 | (282.2) | 108.1 | (75.4) | (46.7) | (30.6) | (17.0) |